Vir Biotechnology, Inc.
(VIR - NASDAQ)
10,64 USD
📋 Profilo Aziendale

Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases.

|